Z-2140-2018 Class III Terminated

Recalled by Alere San Diego Inc. DBA Immunalysis Corporation — Pomona, CA

FDA device recall Z-2140-2018 was initiated by Alere San Diego Inc. DBA Immunalysis Corporation on Nov 28, 2017 and is designated Class III. Reason for recall: The High (125 ng/ml) Control does not meet specification - it has been confirmed to produce values below 100 ng/mL when run on validated clinical chemistry analyzers, which is below the 100 ng/mL… The recall status is terminated (terminated Jan 29, 2021). Affected quantity: 37 kits.

Recall details

Product Type
Devices
Report Date
Jun 20, 2018
Initiation Date
Nov 28, 2017
Termination Date
Jan 29, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
37 kits

Product description

lmmunalysis EDDP Urine Control Set 1 The EDDP Urine Controls (High 125 ng/ml and Low 75 ng/ml) are used as control materials in the ammonolysis EDDP Specific Urine Enzyme Immunoassay, which has a cutoff of 100 ng/ml. This test provides only a preliminary analytical test result and a more specific alternate chemical method, such as Gas Chromatography/Mass Spectrometry or Liquid Chromatography/Tandem Mass Spectrometry, must be used to obtain a confirmed analytical result.

Reason for recall

The High (125 ng/ml) Control does not meet specification - it has been confirmed to produce values below 100 ng/mL when run on validated clinical chemistry analyzers, which is below the 100 ng/mL cutoff of the EDDP Specific Urine Enzyme Immunoassay with which this control is utilized.

Distribution pattern

US Distribution to the states of : CA, CO, CT, FL, LA, MD, NC, NJ, OH, OK, TN, TX, WI, and WV

Code information

Part Number: 3006-5, Lot Number: EK16135

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2140-2018
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2140-2018. Report a data issue: hello@regdatalab.com.